Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
Not Applicable
Recruiting
- Conditions
- Alopecia Areata
- Registration Number
- NCT06564805
- Lead Sponsor
- Universidad Autonoma de Nuevo Leon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusion Criteria:<br><br> - Diagnosis of alopecia areata<br><br> - SALT score of less than 50% extension<br><br> - Has not received any topical or systemic treatment in the last month<br><br> - Signed informed consent<br><br>Exclusion Criteria:<br><br> - Any skin condition on the scalp (infectious, inflammatory or neoplastic) that could<br> modify the clinical of trichoscopic features<br><br> - Pregnancy or breast-feeding<br><br> - Patients in medications that could cause hair loss as side-effects
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment response
- Secondary Outcome Measures
Name Time Method Side effects